Urotronic Inc.
Clinical trials sponsored by Urotronic Inc., explained in plain language.
-
New balloon could ease urinary blockages without surgery
Disease control OngoingThis study tests a special balloon coated with the drug paclitaxel to treat urethral stricture, a narrowing of the urine tube in men. The balloon is inflated to open the stricture and deliver the drug to prevent it from closing again. The trial involves 127 men who have had at le…
Phase: NA • Sponsor: Urotronic Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a Drug-Coated balloon ease an enlarged prostate without surgery?
Symptom relief OngoingThis trial tests a device called the Optilume BPH Catheter System, a balloon coated with the drug paclitaxel that is inflated inside the prostate to widen the urinary passage. The study enrolls men aged 50 to 80 with moderate to severe BPH symptoms who have not responded well to …
Phase: NA • Sponsor: Urotronic Inc. • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
New catheter device offers hope for men with enlarged prostate
Symptom relief OngoingThis study tracks 500 men with symptomatic benign prostatic hyperplasia (BPH) who receive the Optilume BPH Catheter System in real-world clinics. The goal is to see how well the device eases urinary symptoms and how safe it is over 12 months. Participants must follow contraceptio…
Sponsor: Urotronic Inc. • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC